Investors / Qral Ventures
Qral Ventures
Corporate VC
Qral Ventures is the investment arm of Qral Group, a life-sciences management consulting firm. It makes equity investments in healthcare companies and supports them operationally from discovery through commercialization.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechtherapeuticsdiagnosticshealth it
Your fit with Qral Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsQral Ventures lists 10 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (91%) and Industrial & Manufacturing (9%). 67% of its companies are based in United States. It invests most often alongside COLOPL NEXT, City Light and Creative Destruction Lab.
No funding round on record names Qral Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Qral Ventures' whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 96th | 91% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 91% | 15% |
| Industrial & Manufacturing | 9% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Qral Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Bluedot Bio is a biotechnology company producing first-in-class drugs and platform technologies for prevalent diseases, including cancer. | Healthcare & Biotech | Portfolio page | ||
| Floreo develops virtual reality therapy for neurodiverse individuals to practice communication and social skills | Healthcare & Biotech | Portfolio page | ||
| Geneius Biotechnology develops transformative personalized targeted T-cell therapies for cancers. | Healthcare & Biotech | Portfolio page | ||
| Grove Biopharma is pioneering Bionic Biologics, a breakthrough synthetic modality for developing novel therapeutics that target intracellular protein-protein interactions. | Healthcare & Biotech | Portfolio page | ||
| Ikaika Therapeutics is developing first-in-class antibodies with an active pipeline targeting fibrotic diseases, including muscular dystrophy. | Healthcare & Biotech | Portfolio page | ||
| mHUB is where people come to build the physical technologies that will change the physical world. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| The company sells oral care products, including toothpaste and mouthwash, for oral hygiene and health. | Healthcare & Biotech | Portfolio page | ||
| Window Therapeutics is developing breakthrough cancer therapeutics designed to penetrate and permeate into diseased tissue and exert activity specifically against cancer cells and not healthy ones. | Healthcare & Biotech | Portfolio page | ||
| Winterlight has developed a tablet-based assessment that analyzes speech to detect cognitive impairment associated with dementia and mental illness. | Healthcare & Biotech | Portfolio page | ||
| Yobee develops and sells probiotic scalp and skin care products. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- qralventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Qral Ventures' profile as data
Pull Qral Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/qralventures.com
# also
GET /v1/firms/qralventures.com/portfolio
GET /v1/firms/qralventures.com/coinvestors
GET /v1/firms/qralventures.com/news